Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GONB vs Metoclopramide for Acute Migraine
NCT03269435Phase 4Completed
- Sponsor
- Montefiore Medical Center
- Start
- Nov 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in migraine, sponsored by Montefiore Medical Center. Started Nov 2017; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03269435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269435.